Sun Han, Xu Juan, Wang Yangyufan, Shen Siyu, Xu Xingquan, Zhang Lei, Jiang Qing
State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.
Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.
Bioact Mater. 2023 Jan 9;24:477-496. doi: 10.1016/j.bioactmat.2022.12.021. eCollection 2023 Jun.
Large bone defects resulting from fractures and disease are a major clinical challenge, being often unable to heal spontaneously by the body's repair mechanisms. Lines of evidence have shown that hypoxia-induced overproduction of ROS in bone defect region has a major impact on delaying bone regeneration. However, replenishing excess oxygen in a short time cause high oxygen tension that affect the activity of osteoblast precursor cells. Therefore, reasonably restoring the hypoxic condition of bone microenvironment is essential for facilitating bone repair. Herein, we designed ROS scavenging and responsive prolonged oxygen-generating hydrogels (CPP-L/GelMA) as a "bone microenvironment regulative hydrogel" to reverse the hypoxic microenvironment in bone defects region. CPP-L/GelMA hydrogels comprises an antioxidant enzyme catalase (CAT) and ROS-responsive oxygen-releasing nanoparticles (PFC@PLGA/PPS) co-loaded liposome (CCP-L) and GelMA hydrogels. Under hypoxic condition, CPP-L/GelMA can release CAT for degrading hydrogen peroxide to generate oxygen and be triggered by superfluous ROS to continuously release the oxygen for more than 2 weeks. The prolonged oxygen enriched microenvironment generated by CPP-L/GelMA hydrogel significantly enhanced angiogenesis and osteogenesis while inhibited osteoclastogenesis. Finally, CPP-L/GelMA showed excellent bone regeneration effect in a mice skull defect model through the Nrf2-BMAL1-autophagy pathway. Hence, CPP-L/GelMA, as a bone microenvironment regulative hydrogel for bone tissue respiration, can effectively scavenge ROS and provide prolonged oxygen supply according to the demand in bone defect region, possessing of great clinical therapeutic potential.
由骨折和疾病导致的大骨缺损是一项重大临床挑战,身体的修复机制常常无法使其自发愈合。有证据表明,缺氧诱导骨缺损区域活性氧(ROS)过量产生,这对延缓骨再生有重大影响。然而,短时间内补充过量氧气会导致高氧张力,影响成骨细胞前体细胞的活性。因此,合理恢复骨微环境的缺氧状态对于促进骨修复至关重要。在此,我们设计了ROS清除和响应性长效产氧水凝胶(CPP-L/GelMA)作为“骨微环境调节水凝胶”,以逆转骨缺损区域的缺氧微环境。CPP-L/GelMA水凝胶由抗氧化酶过氧化氢酶(CAT)和ROS响应性释氧纳米颗粒(PFC@PLGA/PPS)共负载脂质体(CCP-L)与GelMA水凝胶组成。在缺氧条件下,CPP-L/GelMA可释放CAT以降解过氧化氢产生氧气,并由多余的ROS触发,持续释放氧气超过2周。CPP-L/GelMA水凝胶产生的长效富氧微环境显著增强了血管生成和成骨作用,同时抑制了破骨细胞生成。最后,CPP-L/GelMA在小鼠颅骨缺损模型中通过Nrf2-BMAL1-自噬途径显示出优异的骨再生效果。因此,CPP-L/GelMA作为一种用于骨组织呼吸的骨微环境调节水凝胶,能够有效清除ROS并根据骨缺损区域的需求提供长效氧气供应,具有巨大的临床治疗潜力。